MIRM Mirum Pharmaceuticals, Inc.: institutional ownership and insider trading
349 funds reported holding $9.28B of Mirum Pharmaceuticals, Inc. in their latest 13F filings; in Q2 2026 funds net bought $484M, with 58 new positions and 43 funds selling out; over the last 12 months insiders bought $9.00M and sold $42.2M on the open market; over its last four quarters it reported revenue of $618M and net income of −$860M.
MIRM revenue and earnings
- Quarter ended Jun 30, 2026: revenue $176M, net income −$67.2M, EPS -1.06
- Quarter ended Mar 31, 2026: revenue $160M, net income −$790M, EPS -13.43
- Quarter ended Dec 31, 2025: revenue $149M, net income −$5.73M, EPS -0.10
- Quarter ended Sep 30, 2025: revenue $133M, net income $2.91M, EPS 0.05
Famous investors holding MIRM
- Renaissance Technologies (Renaissance Technologies): $51.8M, 0.1% of the portfolio
- Two Sigma (Two Sigma Investments): $80.8M, 0.1% of the portfolio
- Izzy Englander (Millennium Management): $11.3M, 0.0% of the portfolio
- D. E. Shaw (D. E. Shaw & Co.): $3.26M, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $1.97M, 0.0% of the portfolio
Largest institutional holders of MIRM
- Frazier Life Sciences Management, L.P. — $899M
- Jupiter Topco LLC — $692M
- JANUS HENDERSON GROUP PLC (JHG) — $642M
- BlackRock, Inc. (BLK) — $514M
- FMR LLC — $430M
- PRICE T ROWE ASSOCIATES INC /MD/ — $311M
- VANGUARD PORTFOLIO MANAGEMENT LLC — $278M
- VANGUARD CAPITAL MANAGEMENT LLC — $264M
- STATE STREET CORP (STT, STT-PG) — $254M
- VANGUARD GROUP INC — $205M
Recent MIRM insider trades
- Sep 14, 2026: Bjerkholt Eric sold 9,943 shares ($978K)
- Sep 2, 2026: Howe Jolanda sold 658 shares ($65.8K)
- Sep 1, 2026: Peetz Christopher sold 30,000 shares ($2.96M)
- Aug 18, 2026: Howe Jolanda sold 40,000 shares ($4.00M)
5%+ owners
- JANUS HENDERSON GROUP Ltd.: 9.7% (Schedule 13G/A, filed Aug 13, 2026)
- FMR LLC: 6.2% (Schedule 13G, filed Aug 6, 2026)
- BlackRock, Inc.: 5.7% (Schedule 13G/A, filed Apr 27, 2026)